Company logo.png
A Special Protocol Assessment Agreement Reached with the U.S. Food and Drug Administration for Phase 3 clinical trial of Sovateltide for the treatment of acute cerebral ischemic stroke patients
October 02, 2023 07:25 ET | Pharmazz, Inc.
Special Protocol Assessment Agreement Reached Between Pharmazz, Inc. and the U.S. Food and Drug Administration for Phase 3 Clinical Trial of Sovateltide
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
"Advancements in Acute Ischemic Stroke Therapeutics Market CAGR of 4.6 %: A Ray of Hope for Stroke Patients", Says Market.us
September 25, 2023 09:03 ET | Market.Us
New York, Sept. 25, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Market.us, the Global Acute Ischemic Stroke Therapeutics Market size is expected to be worth around USD 14.0 Billion by...
Vena-Medical-BDAC-FIH-LHSC:
Vena Medical Celebrates First Procedures with Category-Defining Balloon Distal Access Catheter™ (BDAC)
August 16, 2022 10:30 ET | Medical Innovation Xchange
Kitchener, Ontario, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Vena Medical, a leading developer of cutting-edge neurovascular devices, announces the successful treatment of the first five patients in the...
Vena-Medical-BDAC-FIH-LHSC:
Vena Medical Celebrates First Procedures with Category-Defining Balloon Distal Access Catheter™ (BDAC)
August 16, 2022 10:30 ET | Medical Innovation Xchange
Kitchener, Ontario, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Vena Medical, a leading developer of cutting-edge neurovascular devices, announces the successful treatment of the first five patients in the...
American Heart Association Logo
Hospital Uses 'Lean' Manufacturing Techniques to Speed Stroke Care
October 18, 2012 16:00 ET | American Heart Association
Study Highlights: A hospital stroke team used auto industry "lean" manufacturing principles to accelerate stroke treatment times. The average time between patients arriving and receiving...